factors associated with its development, such as hypertension and obesity.
Obstructive sleep apnea (OSA) and sleep-disordered breathing are common among individuals with obesity. 6 Because OSA can both cause and exacerbate existing hypertension 4 and may also contribute to cardiac changes, 7 this extreme form of sleep-disordered breathing is a potential modifiable risk factor for CVD. In terms of a pathophysiologic mechanism, OSA may contribute to LVH through more severe obstructive events leading to greater oxygen deprivation and more nocturnal hypertension, resulting in cardiac remodeling.
With the inherent challenges to effective treatment of obesity, having another treatment target for CVD risk reduction has important clinical implications, particularly for those with obesity who are at increased CVD risk. We therefore sought to determine the association of OSA with left ventricular hypertrophy among a high-risk group: overweight and obese youth with elevated blood pressure. We further sought to determine whether the OSA severity, as defined by the obstructive apneahypopnea index (AHI), was predictive of LVH among these children and adolescents.
The definition of LVH in the pediatric population has been an area of recent debate in the literature. Among specialists who treat children with hypertension, there is "considerable variation in every step of the evaluation of pediatric LVH." 8 Much of the debate centers around how to properly account for the fact that children are actively growing, and whether or not an adult threshold for LVH can be appropriately applied to children. Because of this lack of consensus, we have included three definitions of LVH that have been used in the pediatric literature in our analyses.
| ME THODS

| Study subjects and study design
This was a cross-sectional analysis of data obtained from the baseline visit of consecutive children evaluated in an urban pediatric obesity hypertension clinic between January 1, 2015, and January 1, 2018. The study population consists of overweight and obese patients with a history of elevated blood pressure who were referred for evaluation of hypertension. Informed consent and assent were obtained at the baseline visit for inclusion in the prospective patient
registry. The Institutional Review Board at Johns Hopkins University
School of Medicine approved this study.
| Data collection
| Anthropometric measurements
Height was measured with a stadiometer to the nearest 0.1 cm, and weight was measured (wearing light clothing) by a calibrated standing balance scale to the nearest 0.1 kg. Body mass index (BMI) was calculated as (kg/m 2 ). Height, weight, BMI percentiles, and z-scores were calculated using Centers for Disease Control and Prevention normative growth data. 9, 10 Waist circumference was measured 1 cm above the patients' navel on exhale using a Gulick tape measure which applies known tension. Hip circumference was measured at the widest girth around the hip and buttocks in triplicate.
| Blood pressure measurements
After five minutes of rest, a single study physician (TMB) obtained three manual BP measurements with a calibrated aneroid sphygmomanometer, 30 seconds apart. BP cuffs were selected based on measured mid-arm circumference. The three BP measurements were averaged to provide one overall measurement for the base- 
| Definition of LVH
Standardized two-dimensional guided M-mode echocardiography done within 3 months of the baseline visit was used to determine left ventricular mass, which was calculated using the Devereux The fourth report selected the definition of LVH as LVMI ≥51 g/ m 2.7 , a value that has been associated with a 4-fold greater risk of cardiovascular disease in adults. 15 We chose to include all three definitions of LVH in our analyses for completeness, as the best 
| Definition of OSA
Obstructive sleep apnea was defined based on sleep study results when available within 12 months of the baseline visit (n = 21). In instances where there was no sleep study within this timeframe (n = 34), or there was an intervention to treat OSA after the sleep study (tonsillectomy and adenoidectomy or the use of CPAP with adherence, n = 6), then OSA was defined according to a validated sleep questionnaire. 16, 17 For those children with a sleep study that fell within the criteria above, the severity of the obstructive AHI was categorized as mild, moderate, or severe with 1.5≤ AHI ≤5 defined as mild, 5< AHI ≤10 defined as moderate, and AHI >10 defined as severe. 18 The sleep studies involved full in-laboratory polysomnography, using RemLogic sleep software to collect data. Polysomnography included electroencephalography (EEG), submental and tibial electromyography (EMG), right and left electrooculography (EOG), electrocardiography (ECG), oxygen saturation (SaO 2 ), end-tidal CO 2 , oximeter pulse waveform, audio-and videorecording, nasal airflow monitored with a pressure transducer, as well as thoracic and abdominal plethysmography. Identification and scoring of sleep stages, arousals, and respiratory events were performed in accordance with AASM standards.
| Statistical analysis
Clinical variables were compared between those with and without OSA at baseline visit. Categorical variables were compared using and presence of hypertension, while greater among those with OSA,
| Association of OSA and LVH
were not statistically different between the two groups. 
| OSA severity and LVH
| D ISCUSS I ON
In this cross-sectional analysis of overweight and obese youth with elevated blood pressure, we found that almost half of the cohort had OSA. While striking, this high proportion is consistent with current estimates of OSA prevalence among obese youth. 19 In studies assessing the prevalence of OSA by polysomnography in obese children and adolescents, the prevalence of OSA has varied from 13% to 59%. 20 Previous epidemiological research has found that two important risk factors for sleep-disordered breathing in children are obesity and African American race. 21 These risk factors likely contribute to the high prevalence of OSA in this cohort made up of children from an obesity hypertension clinic, the majority of whom are African American.
Even more remarkable, greater than 70% of the cohort had LVH when defined as LVMI ≥38.6 g/m 2.7 , two-thirds had LVH when defined as LVMI ≥95th percentile, and one-quarter had LVH when defined as LVMI ≥51 g/m 2.7 , a cutoff associated with a 4-fold increase in CV morbidity and mortality in adults. These findings are well above published prevalence estimates for LVH among youth with hypertension, 11, 15 which range from 8% to 41% depending on the definition used. Further, among these overweight and obese children with history of elevated blood pressure, OSA was a significant independent predictor of LVH when defined as LVMI ≥38.6 g/m 2.7 but the most severe form of OSA (severe AHI) was significantly associated with all three definitions of LVH. These findings suggest an important role of this CVD risk factor on intermediate outcomes in a pediatric population at great risk.
Obstructive sleep apnea screening is a recommended step in the evaluation of resistant hypertension. Diagnosis and treatment of OSA can decrease SBP and DBP by 10 mm Hg. 22 Nocturnal hypertension is more common among those with OSA, and hypertension is a known risk factor for LVH. 23 Therefore, identification of pediatric patients with OSA could allow for targeted interventions that have the added benefit of decreasing LVH and thus one's CVD risk.
Individuals with OSA have fragmented sleep, leading to symptoms such as daytime somnolence that may decrease physical activity. OSA can also alter the secretion of hormones that regulate hunger and metabolism, such as leptin and ghrelin. 19 Untreated OSA can therefore lead to dysregulated weight and an increased drive for carbohydrate-rich foods, hindering weight loss efforts and making CVD risk reduction even more challenging. Because of these hormonal and sleep changes that occur in OSA, it is possible that treatment of OSA would help in the effort to decrease BMI.
Further, both obesity and OSA promote inflammation with leptin as well as insulin resistance, factors that can contribute to LVH. 24, 25 This may explain why, while OSA is typically thought to cause right heart disease, OSA was independently associated with cardiac remodeling of the left ventricle in our study. Other studies in different patient populations support our finding. Among adults with OSA diagnosed by sleep study, OSA was a significant independent predictor of LVH, even when controlling for hypertension. 26 In a nonobese, non-hypertensive, largely non-African American pediatric population, AHI was the sole independent predictor of LVMI and severe OSA (AHI >10) was associated with a 11.2 greater odds (95% CI 1.9-64) of LVH (LVMI ≥38.6 g/m 2.7 ) than less severe OSA (AHI <10). 27 Our results show different strengths of association depending on the definition of LVH. This merits discussion in light of the lack of consensus in the pediatric literature regarding LVH. The association of OSA and LVH was the strongest and most consistent when LVH was defined as LVMI ≥38.6 g/m 2.7 . Our goal in this study was not to argue for the best definition of LVH, but rather to investigate the association of OSA and LVH. However, our results suggest that the value of LVMI ≥38.6 g/m 2.7 may be a more sensitive marker for end-organ damage in the pediatric population, as compared to the value of 51 g/m 2.7 which has been associated with increased risk of adverse cardiovascular outcomes in adults.
The important role of sleep on CV health was emphasized in the most recent American Academy of Pediatrics' Clinical Practice
Guideline for pediatric hypertension evaluation and management. 11 Adult studies have demonstrated the strong association of OSA and nocturnal hypoxia with CVD risk. 22, 28 While studied less in children,
recommendations address the need to screen for OSA both in hypertensive youth and in overweight and obese youth via standardized questionnaire as utilized in this study and via less-structured history taking and physical examination.
Additionally, 24-hour ambulatory blood pressure monitoring (ABPM) has been suggested as a tool to identify those with nocturnal hypertension, an entity more common with OSA. 24-hour ABPM can also identify "non-dippers" and "reverse dipper," adverse CVD risk factors in adults that are also associated with OSA. In a study among hypertensive adults, those classified as "non-dippers" based on ABPM results were significantly more likely to have LVH compared to those with the expected dip in nighttime blood pressure. 29 The universal treatment for obesity-related OSA is weight loss.
However, this is a challenging endeavor with a long timeframe for success. Therefore, other treatment approaches such as continuous positive airway pressure (CPAP) and tonsillectomy and adenoidectomy should be considered while individuals work on this critical, but difficult to achieve, 30 factor, because effective OSA treatment reduces both daytime and nighttime blood pressures. 31 While our cross-sectional study cannot show causality, we are hopeful that based on these results future research will investigate the effective treatment of OSA as a potential means to reduce left ventricular mass index in obese children with elevated blood pressure.
Despite the promise of CVD risk reduction with OSA treatment, pediatric providers should recognize that there remain challenges to CPAP adherence among youth. 32, 33 In fact, of the fourteen in- 
| CON CLUS ION
In summary, OSA was found to have a significant association with LVH among obese children and adolescents with history of elevated blood pressure. This cohort had a very high prevalence of LVH, likely a reflection of the extreme level of obesity among these children and adolescents. Those with the most severe form of OSA, with an AHI >10, had the greatest risk for pathologic cardiac remodeling.
Although the study population is a small cohort from a single urban clinic, it provided data from a group of obese children and adolescents at increased CVD risk, with standardized anthropometric, BP, and echocardiography measurements. These data, as well as those from others, suggest that OSA may be an underappreciated CVD risk factor, and one that is treatable if identified. Therefore, screening for OSA should be a consistent part of the evaluation and care of patients with hypertension.
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